Eliksa Therapeutics
Blood & Organ Banks · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3805 Old Easton Rd, Doylestown, Pennsylv...Website
www.eliksa.comRevenue
<$5 MillionIndustry
About Eliksa Therapeutics
Eliksa Therapeutics is a biotechnology company based in Doylestown, Pennsylvania, developing innovative therapies for Epidermolysis bullosa (EB) and related conditions. Leveraging technology licensed from the University of Utah, Eliksas lead program, ELK-003, is a biological eye drop designed to treat corneal abrasions associated with EB.Explore more
Eliksa Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Eliksa Therapeutics Tech Stack
A closer look at the technologies used by Eliksa Therapeutics
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eliksa Therapeutics
Sign Up For FreeTo access detailed company insights
Eliksa Therapeutics is a biotechnology company based in Doylestown, Pennsylvania, developing innovative therapies for Epidermolysis bullosa (EB) and related conditions. Leveraging technology licensed from the University of Utah, Eliksas lead program, ELK-003, is a biological eye drop designed to treat corneal abrasions associated with EB.... Read More
